
Sign up to save your podcasts
Or


Adam P. Dicker, MD, PhD, of the Thomas Jefferson University Sidney Kimmel Cancer Center, walks us through the debate about the value of local treatment for newly diagnosed metastatic prostate cancer.
By American Society of Clinical Oncology (ASCO)4.6
5656 ratings
Adam P. Dicker, MD, PhD, of the Thomas Jefferson University Sidney Kimmel Cancer Center, walks us through the debate about the value of local treatment for newly diagnosed metastatic prostate cancer.

321 Listeners

504 Listeners

39 Listeners

65 Listeners

756 Listeners

121 Listeners

2,262 Listeners

818 Listeners

187 Listeners

46 Listeners

32 Listeners

828 Listeners

59 Listeners

195 Listeners

45 Listeners